Insights & Analysis
Practical guidance on PBM audits, federal investigations, compounding defense, DEA enforcement, telehealth compliance, and the regulatory pressures facing pharmacies and providers nationwide.
More articles — Page 55
Page 55 of 114 · 1029 articles
Individual Accountability in Corporate Healthcare Cases
DOJ's March 2026 Department-wide Corporate Enforcement Policy keeps individual prosecution the priority in corporate healthcare fr…
When to Involve Counsel in a PBM Audit
The audit notice does not announce its own stakes. Which PBM audit decisions actually turn on counsel, and which ones turn on the…
UPIC Revocation Recommendations to CMS
How a UPIC finding becomes a CMS revocation recommendation, the regulatory ground it relies on, and where a physician's response c…
What a PBM Audit Costs an Independent Pharmacy
Recoupment is only one line item. Staff hours, a mid-audit cash-flow offset, and a missed appeal deadline each add their own cost…
UPIC Versus SMRC: Two Different Reviews
SMRC review checks claims against coding rules. UPIC review investigates fraud, with site visits, payment suspension, and a law en…
UPIC Jurisdictions: Which Contractor Covers Your State
CMS assigns UPIC audits to five geographic jurisdictions, each with its own contractor. The current jurisdiction map, and why the…
Selecting a Skin Substitute: Documenting Medical Necessity
How to document product selection, conservative care, and wound measurement so a skin substitute claim holds up under Medicare's 2…
Usual and Customary Price Findings in PBM Audits
PBM auditors treat a pharmacy's usual and customary price as a real, enforceable number. Here is how the finding is calculated, tr…
Insurance Coverage for FCA Defense Costs
A civil investigative demand can trigger D&O coverage before a lawsuit is filed. What a policy actually pays for, and what it excl…